Try our Advanced Search for more refined results
Washington
Washington Law360 provides breaking news and analysis on legal and regulatory issues in Washington. Coverage includes high-stakes litigation, policy developments, and corporate deals affecting the state.
Sign up for a 7-day FREE trial today!
Latest News in Washington
-
March 20, 2026
5th Circ. Wipes Out FTC's TurboTax 'Deceptive' Ad Ruling
The Fifth Circuit on Friday vacated the Federal Trade Commission's cease-and-desist order imposed on Intuit Inc. for its TurboTax advertising that regulators say duped customers into thinking they could file their tax returns for free, saying the agency's in-house decision is unconstitutional, and the dispute must go to federal court.
-
March 20, 2026
CytoDyn Settles Investor Suit With $500K, 49M Shares
Biotechnology firm CytoDyn has agreed to dole out 49 million shares of common stock and pay $500,000 to end investors' proposed class action accusing the company of overstating the likelihood that the U.S. Food and Drug Administration would approve a drug it claimed could treat HIV and COVID-19.
-
March 20, 2026
Feds To Cover Ayahuasca Church's Legal Fees, 9th Circ. Says
The federal government is on the hook for more than $2 million in attorney fees following a settlement with a Phoenix-based church over its right to use the psychedelic beverage ayahuasca in religious ceremonies, a divided Ninth Circuit panel said in an unpublished opinion Friday.
-
March 20, 2026
Real Estate Recap: Rate Hold, Data Center Regs, Housing EOs
Catch up on this past week's key developments by state from Law360 Real Estate Authority — including reactions to the latest interest rates news from the Fed, states tamping down on data center development and executive orders on the affordable housing front.
-
March 20, 2026
Eli Lilly Beats 9th Circ. Appeal Over Brain Bleed After Cialis
A Ninth Circuit panel Friday upheld Eli Lilly and Co.'s win over a Washington man who claimed the company's erectile dysfunction drug Cialis caused bleeding in his brain, ruling David Dearinger failed to establish that doctors would have acted differently had they been warned of the medication's risks.
Areas of Coverage
- AGENCIES
- Washington Attorney General’s
- Washington Utilities and Transportation Commission
- Washington State Department of Ecology
- Washington State Department of Health
- Washington State Department of Labor and Industries
- ENFORCEMENT
- Investigations and enforcement actions by state and federal prosecutors
- LITIGATION
- Antitrust litigation
- Class actions
- Environmental suits
- Labor and employment issues
- Intellectual property cases
- Product liability and consumer protection disputes
- Securities disputes
- Bankruptcy proceedings
- Appellate rulings
- TRANSACTIONS
- Mergers, acquisitions, and joint ventures involving Washington companies
- Real estate deals
- PROFILES
- Nominations, appointments, and elections of judges and agency officials in Washington State
- Personnel moves
- Profiles of Washington State judges, litigators, and firms
Readership
- Lawyers at top law firms practicing in Washington State
- Corporate counsel and compliance officers at Fortune 1000 companies
- Executives and attorneys working with Washington State-based companies
- Information experts at law firms, agencies, and companies
- Policymakers at federal and state agencies
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.
- Attorney and law firm marketing professionals